Drug Trial Radar · NCT03032380
Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens
Last checked: Nov 20, 2026Latest source record: Nov 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Oct 24, 2017
Primary completion
Feb 26, 2019
Study completion Apr 1, 2019
Sponsor
- Lead sponsor
- ShionogiIndustry
- Sponsor type
- Industry
- First posted
- Jan 26, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to compare all-cause mortality at Day 14 in participants receiving cefiderocol with participants receiving the comparator, meropenem, in adults with hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), or healthcare-associated bacterial pneumonia (HCABP) caused by Gram-negative pathogens.
Conditions
- Healthcare-associated Pneumonia (HCAP)
- Hospital Acquired Pneumonia (HAP)
- Ventilator Associated Pneumonia (VAP)
Interventions
CefiderocolDrug
2000 mg intravenously every 8 hours for a period of 7 to14 days (dosage adjustment is necessary based on renal function)
MeropenemDrug
2000 mg intravenously every 8 hours for a period of 7 to 14 days (dosage adjustment is necessary based on renal function)
LinezolidDrug
600 mg of linezolid administered intravenously over 30 minutes to 2 hours, every 12 hours.
Primary outcomes
What the sponsor says the trial is designed to measure.
- All-cause Mortality Rate at Day 14Time frame: From first dose of study drug to Day 14
Locations
119 sites in 19 countries. Site status is shown where the registry gives one.
Shionogi Research Site
New Haven, Connecticut
Shionogi Research Site
DeLand, Florida
Shionogi Research Site
Chicago, Illinois
Shionogi Research Site
Council Bluffs, Iowa
Shionogi Research Site
Louisville, Kentucky
Shionogi Research Site
Baton Rouge, Louisiana
Shionogi Research Site
Shreveport, Louisiana
Shionogi Research Site
Annapolis, Maryland
Shionogi Research Site
Detroit, Michigan
Shionogi Research Site
St Louis, Missouri
Shionogi Research Site
Cleveland, Ohio
Shionogi Research Site
Columbus, Ohio
Shionogi Research Site
Bethlehem, Pennsylvania
Shionogi Research Site
Philadelphia, Pennsylvania
Shionogi Research Site
Salt Lake City, Utah
Shionogi Research Site
Brussels, Belgium
Shionogi Research Site
Brussels, Belgium
Shionogi Research Site
Halifax, Nova Scotia, Canada
Shionogi Research Site
Kingston, Ontario, Canada
Shionogi Research Site
Brno, Czechia
Shionogi Research Site
Hradec Králové, Czechia
Shionogi Research Site
Kolín, Czechia
Shionogi Research Site
Kyjov, Czechia
Shionogi Research Site
Ostrava-Poruba, Czechia
Shionogi Research Site
Prague, Czechia
Shionogi Research Site
Příbram, Czechia
Shionogi Research Site
Kohtla-Järve, Estonia
Shionogi Research Site
Pärnu, Estonia
Shionogi Research Site
Tallinn, Estonia
Shionogi Research Site
Tartu, Estonia
Shionogi Research Site
Angers, France
Shionogi Research Site
Argenteuil, France
Shionogi Research Site
Bron, France
Shionogi Research Site
LaRoche-sur-Yon, France
Shionogi Research Site
Lyon, France
Shionogi Research Site
Nice, France
Shionogi Research Site
Paris, France
Shionogi Research Site
Batumi, Georgia
Shionogi Research Site
Kutaisi, Georgia
Shionogi Research Site
Kutaisi, Georgia
Showing 40 of 119 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.